BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 11858106)

  • 1. [Sinus node functions, sinoatrial conduction, atrial conductivity after incipient paroxysms of atrial fibrillation and flutter in patients with ischemic heart disease].
    Olesin AI; Shabrov AV; Razumova TV; Sinenko VI; Aleksandrov VS
    Ter Arkh; 2001; 73(12):40-4. PubMed ID: 11858106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Various regimes of cardiostimulation in determination of anti-recurrence therapy of atrial fibrillation and flutter paroxysms in patients with ischemic heart disease].
    Olesin AI; Shabrov AV; Razumova TV; Aleksandrov VS
    Ter Arkh; 2000; 72(11):39-43. PubMed ID: 11270955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The differentiated therapy of paroxysms of atrial fibrillation and flutter in patients with ischemic heart disease in relation to the duration of the arrhythmia before the start of treatment].
    Shabrov AV; Olesin AI; Golub IaV; Smolin ZIu
    Ter Arkh; 1998; 70(8):25-9. PubMed ID: 9770739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter.
    Ahmari SA; Bunch TJ; Chandra A; Chandra V; Ujino K; Daly RC; Kushwaha SS; Edwards BS; Maalouf YF; Seward JB; McGregor CG; Chandrasekaran K
    J Heart Lung Transplant; 2006 Jan; 25(1):53-60. PubMed ID: 16399531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized study comparing combined pulmonary vein-left atrial junction disconnection and cavotricuspid isthmus ablation versus pulmonary vein-left atrial junction disconnection alone in patients presenting with typical atrial flutter and atrial fibrillation.
    Wazni O; Marrouche NF; Martin DO; Gillinov AM; Saliba W; Saad E; Klein A; Bhargava M; Bash D; Schweikert R; Erciyes D; Abdul-Karim A; Brachman J; Gunther J; Pisano E; Potenza D; Fanelli R; Natale A
    Circulation; 2003 Nov; 108(20):2479-83. PubMed ID: 14610012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can common-type atrial flutter be a sign of an arrhythmogenic substrate in paroxysmal atrial fibrillation? Clinical and ablative consequences in patients with coexistent paroxysmal atrial fibrillation/atrial flutter.
    Moreira W; Timmermans C; Wellens HJ; Mizusawa Y; Philippens S; Perez D; Rodriguez LM
    Circulation; 2007 Dec; 116(24):2786-92. PubMed ID: 18040030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial fibrillation recurrence after drug-induced typical atrial flutter ablation.
    Bandini A; Golia P; Pantoli D; Galvani M; Rusticali F
    Ital Heart J; 2005 Jul; 6(7):584-90. PubMed ID: 16274021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.
    Chiladakis JA; Kalogeropoulos A; Patsouras N; Manolis AS
    J Am Coll Cardiol; 2004 Aug; 44(4):859-63. PubMed ID: 15312872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Celivarone for maintenance of sinus rhythm and conversion of atrial fibrillation/flutter.
    Khitri AR; Aliot EM; Capucci A; Connolly SJ; Crijns H; Hohnloser SH; Kulakowski P; Roy D; Radzik D; Kowey PR
    J Cardiovasc Electrophysiol; 2012 May; 23(5):462-72. PubMed ID: 22171925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The treatment of paroxysmal supraventricular arrhythmias in IHD patients with a high risk of developing complications from the anti-arrhythmic therapy].
    Andriushchenko OM; Olesin AI
    Ter Arkh; 1996; 68(5):57-60. PubMed ID: 9082603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gap junction modifier, GAP-134 [(2S,4R)-1-(2-aminoacetyl)-4-benzamido-pyrrolidine-2-carboxylic acid], improves conduction and reduces atrial fibrillation/flutter in the canine sterile pericarditis model.
    Rossman EI; Liu K; Morgan GA; Swillo RE; Krueger JA; Gardell SJ; Butera J; Gruver M; Kantrowitz J; Feldman HS; Petersen JS; Haugan K; Hennan JK
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1127-33. PubMed ID: 19252062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immediate cardioversion of atrial fibrillation and atrial flutter lasting less than 90 days by ibutilide versus propafenone: a multicenter study].
    Zhang HC; Guo JH; Fang Q; Zheng YA; Sun YM; Zhu WQ; Wan Z; Guo JX; Ge JB; Han SM
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(12):798-801. PubMed ID: 15949393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sinus node function, sinoatrial and atrial conduction and the nature of the course of supraventricular heart rate disorders in IHD patients before and after aortocoronary bypass].
    Litvinenko VA; Olesin AI; Andriushchenko OM; Borisov IA; Shilov VV
    Ter Arkh; 1996; 68(2):34-7. PubMed ID: 8771654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reverse remodeling of sinus node function after catheter ablation of atrial fibrillation in patients with prolonged sinus pauses.
    Hocini M; Sanders P; Deisenhofer I; Jaïs P; Hsu LF; Scavée C; Weerasoriya R; Raybaud F; Macle L; Shah DC; Garrigue S; Le Metayer P; Clémenty J; Haïssaguerre M
    Circulation; 2003 Sep; 108(10):1172-5. PubMed ID: 12952840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial septal pacing to prevent atrial fibrillation in patients with sinus node dysfunction: results of a randomized controlled study.
    Hermida JS; Kubala M; Lescure FX; Delonca J; Clerc J; Otmani A; Jarry G; Rey JL
    Am Heart J; 2004 Aug; 148(2):312-7. PubMed ID: 15309002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents.
    Hongo RH; Themistoclakis S; Raviele A; Bonso A; Rossillo A; Glatter KA; Yang Y; Scheinman MM
    J Am Coll Cardiol; 2004 Aug; 44(4):864-8. PubMed ID: 15312873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of radiofrequency ablation of atrial flutter on the natural history of subsequent atrial arrhythmias.
    Luria DM; Hodge DO; Monahan KH; Haroldson JM; Shen WK; Asirvatham SJ; Hammill SC; Munger TM; Glikson M; Gersh BJ; Packer DL; Friedman PA
    J Cardiovasc Electrophysiol; 2008 Nov; 19(11):1145-50. PubMed ID: 18554204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of ibutilide for cardioversion of atrial flutter and fibrillation in patients receiving amiodarone or propafenone.
    Fragakis N; Papadopoulos N; Papanastasiou S; Kozirakis M; Maligkos G; Tsaritsaniotis E; Katsaris G
    Pacing Clin Electrophysiol; 2005 Sep; 28(9):954-61. PubMed ID: 16176535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Determination of the end-point of the radiofrequency linear lesion in the subeustachian isthmus and its relation to treatment of atrial flutter and fibrillation. Acute and long-term results in 90 patients].
    Fiala M; Heinc P; Lukl J
    Vnitr Lek; 2002 Mar; 48(3):202-9. PubMed ID: 11968581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results from the Loire-Ardèche-Drôme-Isère-Puy-de-Dôme (LADIP) trial on atrial flutter, a multicentric prospective randomized study comparing amiodarone and radiofrequency ablation after the first episode of symptomatic atrial flutter.
    Da Costa A; Thévenin J; Roche F; Romeyer-Bouchard C; Abdellaoui L; Messier M; Denis L; Faure E; Gonthier R; Kruszynski G; Pages JM; Bonijoly S; Lamaison D; Defaye P; Barthélemy JC; Gouttard T; Isaaz K;
    Circulation; 2006 Oct; 114(16):1676-81. PubMed ID: 17030680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.